Contact Us
Blog
Hurley McKenna & Mertz, P.C.

OtisMed recall, knee replacement liability, Chicago injury attorneyThe OtisKnee device, made by OtisMed Corporation, was not approved by the Food and Drug Administration (FDA) to be used in knee replacement surgeries. The OtisKnee devices were not proven to be safe or effective. OtisMed Corporation distributed and marketed the OtisKnee and is responsible for product liability and the injuries patients have been caused due to the defective product.

“The OtisKnee device was used by surgeons performing total knee arthroplasty, known as knee replacement surgery. OtisMed advertised the cutting guide as a tool to assist surgeons in making accurate bone cuts specific to individual patients’ anatomy based on magnetic resonance imaging (MRI) performed prior to surgery,” according to the FDA’s statement about the OtisKnee, following a lengthy investigation.

The OtisKnee device was marketed to surgeons as a means to match the size and placement of the implant to an individual’s normal knee alignment. It was supposed to allow surgeons to be able to keep more of the patient’s bone and ligaments, which meant a quicker recovery and greater range of motion. Patients claimed their recovery was longer and many have had to undergo a second knee replacement surgery to remove the defective product, more bone, and have a new implant placed in their knee, costing them more recovery time and more medical expenses.

...

Stryker hip implant settlement, Chicago product liability attorneyA settlement involving a minimum award of $1.43 billion has been reached in ongoing product liability litigation against Stryker Orthopedics. The 3,000-plus clients represented in the Stryker hip implant lawsuit will each receive a base amount of $300,000 with additional compensation for those who suffered revision surgery complications to remove the defective hip implant.

Stryker manufactured and promoted its Rejuvenate and ABG II Modular-Neck Hips implants as having the capability of providing longer life and greater range of motion for patients. The FDA approved Stryker’s Rejuvenate Modular hip system in 2008 as part of a 510(k) premarket application, which determined the hip implant was “substantially equivalent” to pre-approved, legally marketed medical devices.

The Centers for Disease Control and Prevention reported 332,000 hip replacements in 2010. Two years later, Stryker issued a recall of its Rejuvenate and ABG II Modular-Neck Hips implants due to dangers resulting from the poor design and improper testing of the device. Studies showed that patients faced health risks including:

...

stryker hip replacement recallThe American Academy of Orthopaedic Surgeons has reported more than 285,000 hip replacements are performed each year in the U.S. Stryker, a medical device manufacturer, marketed metal-on-metal artificial hips as having the capability to last longer in patients and provide a broader range of motion. The design of metal-on-metal hips involves both the ball and socket components being made from metals such as chromium or cobalt.

In 2011, these artificial hips accounted for approximately one-third of hip replacement procedures. However, due to product failure, Stryker voluntarily issued a hip recall for its ABG II and Rejuvenate hip devices and shut down global distribution of these products in 2012.

According to The New York Times, as patients continued to encounter problems with their artificial hips, the FDA ordered studies of all artificial hip producers to address concerns and determine whether the hip implants were shedding an exorbitant amount of metal debris.

...

Hurley McKenna & Mertz, P.C. recently filed lawsuits in federal court on behalf of seven individuals who received defective Stryker hip implants.  In July 2012, Stryker issued a voluntary worldwide recall of its Rejuvenate and ABG II hip implants.  Studies have shown that these implants corrode over time, which causes bits of metal to leak into patients’ bodies, leading to major health complications.

One of the most common health problems associated with the Stryker Rejuvenate and ABG II hip implants is metallosis.  Metallosis is an adverse tissue reaction to heavy metals in the body that can cause limited mobility, failure of the hip joint, pseudotumors, and dissolution of the bone.

Many individuals who received the Rejuvenate or ABG II implant require painful revision surgery to remove the defective device.  Revision surgery is a complicated procedure that leads to a long, painful recovery.

...

NBC TV interviews Chris Hurley and Mark Stephan about Stryker Defective Hip Lawsuit from Christopher Hurley on Vimeo.

In 2007, Mark Stephan suffered catastrophic injuries when his front wheel unexpectedly disengaged from his bicycle. This crash paralyzed Mark from the neck down. Since then, Mark has refused to let this horrific injury hold him back. Mark has continuously shattered all expectations, achieving such feats as climbing 103 floors to the top of the Willis Tower and cycling 3,129 miles across the southern United States.

...
Waiting for Resize
To Top